Back

dr. R.S. (Rachel) van Leeuwaarde

PHD Candidate - Medical

  • Department of Endrocine Oncology

Research Programs

Research Output (21)

Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Is There Any Benefit When Ki-67 Is >= 10%?

Merola E., Gordoa Alonso T., Zhang P., Al-Toubah T., Pelle E., Liu M., Laskaratos F., de Mestier L., Lamarca A., Hernando J., Cives M., van Leeuwaarde R. mrt 2020, In: Neuroendocrinology. 110 , p. 197-197

Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS):a single-centre, single-arm, open-label, phase 2 study

Braat Arthur J A T, Bruijnen Rutger C G, van Rooij Rob, Braat Manon N G J A, Wessels Frank J, van Leeuwaarde Rachel S, van Treijen Mark J C, de Herder Wouter W, Hofland Johannes, Tesselaar Margot E T, de Jong Hugo W A M, Lam Marnix G E H 26 feb 2020, In: LANCET ONCOLOGY. 21 , p. 561-570 10 p.

Clinical Relevance of Genetic Analysis in Patients With Pituitary Adenomas:A Systematic Review

van den Broek Medard F M, van Nesselrooij Bernadette P M, Verrijn Stuart Annemarie A, van Leeuwaarde Rachel S, Valk Gerlof D 10 dec 2019, In: Frontiers in Endocrinology. 10 16 p.

Biochemically Silent Sympathetic Paraganglioma, Pheochromocytoma, or Metastatic Disease in SDHD Mutation Carriers

Dreijerink Koen M.A., Rijken Johannes A., Compaijen C. J., Timmers Henri J.L.M., van der Horst-Schrivers Anouk N.A., van Leeuwaarde Rachel S., van Dam P. Sytze, Leemans C. René, van Dam Eveline W.C.M., Dickhoff Chris, Dommering Charlotte J., de Graaf Pim, Zwezerijnen G. J.C., van der Valk Paul, Menke-Van der Houven van Oordt C. Willemien, Hensen Erik F., Corssmit Eleonora P.M., Eekhoff E. Marelise W. 1 nov 2019, In: The Journal of clinical endocrinology and metabolism. 104 , p. 5421-5426 6 p.

The incidence of consecutive manifestations in Von Hippel-Lindau disease

van der Horst-Schrivers Anouk N A, Sluiter Wim J, Kruizinga Roeliene C, van Leeuwaarde Rachel S, Giles Rachel, Olderode-Berends Maran J W, Links Thera P 13 mei 2019, In: Familial Cancer. 18 , p. 369-376 8 p.

First Experience with 177Lu-PSMA-617 Therapy for Advanced Prostate Cancer in the Netherlands

van Kalmthout Ludwike, Braat Arthur, Lam Marnix, van Leeuwaarde Rachel, Krijger Gerard, Ververs Tessa, Mehra Niven, Bins Adriaan, Hunting Jarmo, de Keizer Bart 12 apr 2019, In: Clinical Nuclear Medicine. 44 , p. 446-451 6 p.

Multiple Endocrine Neoplasia Type 1: The impact of screening:Results of the DutchMEN1 Study Group

van Leeuwaarde R.S. 11 apr 2019, 150 p.

Using Adult Stem Cell-Derived Organoids to Model Neuroendocrine Neoplasms

Dayton T., Den Hartigh L., McFaline J. L., Van Leeuwaarde R., Valk G. D., Van den Berg J., Tesselaar M., Vriens M., Lopes Chuva de Sousa S. M., Fernandez-Cuesta L., Trapnell C., Clevers H. 2019, In: Neuroendocrinology. 108 , p. 18-18

Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study

van Treijen Mark J. C., Korse Catharina M., van Leeuwaarde Rachel S., Saveur Lisette J., Vriens Menno R., Verbeek Wieke H. M., Tesselaar Margot E. T., Valk Gerlof D. 4 dec 2018, In: Frontiers in Endocrinology. 9

Diagnosing Nonfunctional Pancreatic NETs in MEN1:The Evidence Base

van Treijen Mark J. C., van Beek Dirk-Jan, van Leeuwaarde Rachel S., Vriens Menno R., Valk Gerlof D. 1 sep 2018, In: JOURNAL OF THE ENDOCRINE SOCIETY. 2 , p. 1067-1088 22 p.

All Research Output (21)